A retrospective to explain effectiveness of chemotherapy after nivolumab treatment in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Latest Information Update: 17 Dec 2020
At a glance
- Drugs Nivolumab (Primary) ; Antineoplastics; Cetuximab; Gimeracil/oteracil/tegafur; Paclitaxel
- Indications Cancer metastases; Carcinoma; Head and neck cancer; Hypopharyngeal cancer; Laryngeal cancer; Mouth neoplasm; Nasopharyngeal cancer; Oropharyngeal cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 17 Dec 2020 New trial record